Another recent meta-analysis demonstrated about 3-fold higher levels of IL6 in patients with severe COVID19 as compared with patients with nonsevere disease (Coomes and Haghbayan, 2020), suggesting that the inhibition of IL6 may represent a potential novel target in COVID19 treatment. Here, IL6 is linked to COVID-19.